FDA OKs Lymphoma 'Breakthrough' Drug

Thursday, 14 Nov 2013 08:15 AM

 

Share:
  Comment  |
   Contact Us  |
  Print  
|  A   A  
  Copy Shortlink
U.S. health regulators on Wednesday approved a drug to treat a rare and aggressive form of non-Hodgkin lymphoma developed by Johnson & Johnson and Pharmacyclics Inc, marking the second drug that received the FDA's new breakthrough therapy designation to gain approval.

The drug, to be sold under the brand name, Imbruvica, and known chemically as ibrutinib, was approved to treat mantle cell lymphoma in patients who have received prior treatment with at least one other medicine, such as Celgene Corp's Revlimid.
 
Mantle cell lymphoma represents about 6 percent of non-Hodgkin lymphoma cases in the United States and has typically spread to lymph nodes, bone marrow and other organs by the time it is diagnosed, the Food and Drug Administration said.

Obamacare: Massive New Rules Revealed for 2013

© 2014 Thomson/Reuters. All rights reserved.

Share:
  Comment  |
   Contact Us  |
  Print  
  Copy Shortlink
Around the Web
Join the Newsmax Community
Please review Community Guidelines before posting a comment.
>> Register to share your comments with the community.
>> Login if you are already a member.
blog comments powered by Disqus
 
Email:
Retype Email:
Country
Zip Code:
Privacy: We never share your email.
 
Hot Topics
Follow Newsmax
Like us
on Facebook
Follow us
on Twitter
Add us
on Google Plus
Around the Web
You May Also Like

Sierra Leone Makes It Illegal to Hide Ebola Patients

Saturday, 23 Aug 2014 09:37 AM

Sierra Leone voted to pass a new amendment to its health act, imposing possible jail time for anyone caught hiding an Eb . . .

Mammogram False Alarms Linked to Later Breast Cancer

Saturday, 23 Aug 2014 09:28 AM

Women whose screening mammograms produce false alarms have a heightened risk of being diagnosed with breast cancer years . . .

One Part of Brain Doesn't Age, Researchers Say

Friday, 22 Aug 2014 16:29 PM

At least one part of an older person's brain can still process information as well as younger people, according to new r . . .

Most Commented

Newsmax, Moneynews, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, NewsmaxWorld, NewsmaxHealth, are trademarks of Newsmax Media, Inc.

 
NEWSMAX.COM
America's News Page
©  Newsmax Media, Inc.
All Rights Reserved